OpGen Stock Price, News & Analysis (NASDAQ:OPGN)

$0.20 -0.01 (-2.99 %)
(As of 12/17/2017 12:28 PM ET)
Previous Close$0.20
Today's Range$0.19 - $0.21
52-Week Range$0.18 - $1.85
Volume1.08 million shs
Average Volume1.06 million shs
Market Capitalization$11 million
P/E RatioN/A
Dividend YieldN/A
Beta0.96

About OpGen (NASDAQ:OPGN)

OpGen logoOpGen, Inc. (OpGen) is a precision medicine company using molecular diagnostics and informatics to combat infectious disease. The Company is engaged in developing molecular information solutions to combat infectious disease in global healthcare settings, helping to guide clinicians with information about life threatening infections, managing patient outcomes, and the spread of infections caused by multidrug-resistant microorganisms. Its deoxyribonucleic acid (DNA) tests and bioinformatics address the threat of anti-biotic resistance by helping physicians and healthcare providers manage patient care decisions and protect the hospital biome through customized screening and surveillance solutions. It is working to deliver its molecular information solution to a global network of customers and partners. It is also working to provide precise diagnostic information powered by pathogen surveillance data. The Company's high-resolution DNA tests are marketed under the Acuitas trade name.

Receive OPGN News and Ratings via Email

Sign-up to receive the latest news and ratings for OPGN and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology & Medical Research
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:OPGN
CUSIPN/A
Phone240-813-1260

Debt

Debt-to-Equity Ratio0.03%
Current Ratio1.23%
Quick Ratio1.13%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$4.03 million
Price / Sales2.73
Cash FlowN/A
Price / CashN/A
Book Value$0.15 per share
Price / Book1.30

Profitability

Trailing EPS($0.62)
Net Income$-19,160,000.00
Net Margins-533.47%
Return on Equity-1,289.51%
Return on Assets-234.78%

Miscellaneous

Employees62
Outstanding Shares56,430,000

OpGen (NASDAQ:OPGN) Frequently Asked Questions

What is OpGen's stock symbol?

OpGen trades on the NASDAQ under the ticker symbol "OPGN."

How were OpGen's earnings last quarter?

OpGen, Inc. (NASDAQ:OPGN) issued its quarterly earnings data on Thursday, May, 12th. The medical research company reported ($0.36) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.30) by $0.06. The medical research company earned $1.10 million during the quarter. OpGen had a negative return on equity of 1,289.51% and a negative net margin of 533.47%. View OpGen's Earnings History.

Where is OpGen's stock going? Where will OpGen's stock price be in 2017?

2 Wall Street analysts have issued 12-month price targets for OpGen's shares. Their forecasts range from $1.00 to $1.00. On average, they expect OpGen's share price to reach $1.00 in the next year. View Analyst Ratings for OpGen.

What are Wall Street analysts saying about OpGen stock?

Here are some recent quotes from research analysts about OpGen stock:

  • 1. According to Zacks Investment Research, "OpGen, Inc. is a microbial genetics analysis company. The Company offers optical mapping services for analysis of microbial, yeast and fungal genomic architecture. OpGen, Inc. headquartered in Gaithersburg, Maryland. " (11/14/2017)
  • 2. HC Wainwright analysts commented, "We note that these results reflect the company’s ongoing efforts to reduce operating expenses. Of note, management expects a further decline in operating expenses by 25-30% in 2H 2017, as compared to 1H 2017. OpGen is in the process of consolidating its manufacturing footprint and prioritizing R&D spending to develop the Acuitas rapid test. Management indicated that the company would make efforts to maintain gross margins within the historical range of 40-60%, which would be a healthy level, in our view. Evidently, the company aims to be capital efficient, which may boost shareholder value in the near term." (8/9/2017)

Who are some of OpGen's key competitors?

Who are OpGen's key executives?

OpGen's management team includes the folowing people:

  • Evan Jones, Chairman of the Board, Chief Executive Officer (Age 60)
  • Timothy C. Dec, Chief Financial Officer, Corporate Secretary (Age 58)
  • Geoffrey A. McKinley Ph.D., Senior Vice President - Research and Development and Business Development (Age 65)
  • G. Terrance Walker Ph.D., Senior Vice President - Research and Development (Age 58)
  • Vadim Sapiro, Chief Information Officer (Age 46)
  • Robert McG. Lilley, Chief Commercial Officer (Age 71)
  • Brian G. Atwood, Independent Director (Age 64)
  • Harry J. D'Andrea, Independent Director (Age 60)
  • Timothy J. R. Harris Ph.D., Independent Director (Age 66)
  • Tina Susan Nova Ph.D., Independent Director (Age 63)

When did OpGen IPO?

(OPGN) raised $17 million in an IPO on Tuesday, May 5th 2015. The company issued 2,900,000 shares at $5.50-$6.50 per share. Maxim Group served as the underwriter for the IPO and National Securities was co-manager.

Who owns OpGen stock?

OpGen's stock is owned by a number of of institutional and retail investors. Top institutional investors include Perkins Capital Management Inc. (2.72%). Company insiders that own OpGen stock include Jven Capital, Llc and Timothy C Dec. View Institutional Ownership Trends for OpGen.

Who bought OpGen stock? Who is buying OpGen stock?

OpGen's stock was acquired by a variety of institutional investors in the last quarter, including Perkins Capital Management Inc.. Company insiders that have bought OpGen stock in the last two years include Jven Capital, Llc and Timothy C Dec. View Insider Buying and Selling for OpGen.

How do I buy OpGen stock?

Shares of OpGen can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OpGen's stock price today?

One share of OpGen stock can currently be purchased for approximately $0.20.

How big of a company is OpGen?

OpGen has a market capitalization of $11 million and generates $4.03 million in revenue each year. The medical research company earns $-19,160,000.00 in net income (profit) each year or ($0.62) on an earnings per share basis. OpGen employs 62 workers across the globe.

How can I contact OpGen?

OpGen's mailing address is 708 QUINCE ORCHARD ROAD SUITE 205, GAITHERSBURG MD, 20878. The medical research company can be reached via phone at 240-813-1260 or via email at [email protected]


MarketBeat Community Rating for OpGen (OPGN)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  64 (Vote Outperform)
Underperform Votes:  75 (Vote Underperform)
Total Votes:  139
MarketBeat's community ratings are surveys of what our community members think about OpGen and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

OpGen (NASDAQ:OPGN) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $2.15$2.15$2.15$2.65
Price Target Upside: 656.78% upside656.78% upside607.24% upside258.69% upside

OpGen (NASDAQ:OPGN) Consensus Price Target History

Price Target History for OpGen (NASDAQ:OPGN)

OpGen (NASDAQ:OPGN) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/8/2017HC WainwrightReiterated RatingBuy$1.00N/AView Rating Details
6/19/2017Dawson JamesReiterated RatingBuyLowView Rating Details
8/10/2016Rodman & RenshawSet Price TargetBuy$3.30N/AView Rating Details
(Data available from 12/17/2015 forward)

Earnings

OpGen (NASDAQ:OPGN) Earnings History and Estimates Chart

Earnings by Quarter for OpGen (NASDAQ:OPGN)

OpGen (NASDAQ OPGN) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/24/2016Q3($0.27)($0.23)$1.10 million$0.73 millionViewListenView Earnings Details
5/12/2016Q1($0.30)($0.36)$1.10 millionViewListenView Earnings Details
3/30/2016Q4($0.38)$1.33 millionViewListenView Earnings Details
11/12/2015Q315($0.38)$0.98 millionViewListenView Earnings Details
8/13/2015Q215($0.84)$1.10 million$0.38 millionViewListenView Earnings Details
6/17/2015Q115($5.61)$0.47 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

OpGen (NASDAQ:OPGN) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.41 EPS
Next Year EPS Consensus Estimate: $-0.15 EPS

Dividends

Dividend History for OpGen (NASDAQ:OPGN)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

OpGen (NASDAQ OPGN) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 31.83%
Institutional Ownership Percentage: 12.21%
Insider Trades by Quarter for OpGen (NASDAQ:OPGN)
Insider Trades by Quarter for OpGen (NASDAQ:OPGN)

OpGen (NASDAQ OPGN) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/18/2017Jven Capital, LlcChairmanBuy1,875,000$0.40$750,000.00View SEC Filing  
7/18/2017Timothy C DecCFOBuy65,000$0.40$26,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

OpGen (NASDAQ OPGN) News Headlines

Source:
DateHeadline
ETFs with exposure to OpGen, Inc. : December 11, 2017ETFs with exposure to OpGen, Inc. : December 11, 2017
finance.yahoo.com - December 11 at 4:48 PM
 OpGen, Inc. (OPGN) Given Consensus Recommendation of "Strong Buy" by Brokerages OpGen, Inc. (OPGN) Given Consensus Recommendation of "Strong Buy" by Brokerages
www.americanbankingnews.com - December 10 at 9:58 PM
Head to Head Analysis: OpGen (OPGN) versus The CompetitionHead to Head Analysis: OpGen (OPGN) versus The Competition
www.americanbankingnews.com - December 9 at 1:22 AM
OpGen, Inc. (OPGN) Expected to Announce Quarterly Sales of $910,000.00OpGen, Inc. (OPGN) Expected to Announce Quarterly Sales of $910,000.00
www.americanbankingnews.com - December 2 at 6:54 AM
Should You Be Content With OpGen Inc’s (OPGN) 56.9% Earnings Growth?Should You Be Content With OpGen Inc’s (OPGN) 56.9% Earnings Growth?
finance.yahoo.com - November 30 at 4:37 PM
ETFs with exposure to OpGen, Inc. : November 30, 2017ETFs with exposure to OpGen, Inc. : November 30, 2017
finance.yahoo.com - November 30 at 4:37 PM
 Brokerages Anticipate OpGen, Inc. (OPGN) Will Announce Earnings of -$0.06 Per Share Brokerages Anticipate OpGen, Inc. (OPGN) Will Announce Earnings of -$0.06 Per Share
www.americanbankingnews.com - November 30 at 1:46 PM
Zacks: OpGen, Inc. (OPGN) Given Average Rating of "Strong Buy" by AnalystsZacks: OpGen, Inc. (OPGN) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - November 30 at 1:28 AM
OpGen, Inc. :OPGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017OpGen, Inc. :OPGN-US: Earnings Analysis: Q3, 2017 By the Numbers : November 29, 2017
finance.yahoo.com - November 29 at 10:22 AM
What Falling Estimates & Price Mean for INC Research (INCR)What Falling Estimates & Price Mean for INC Research (INCR)
www.zacks.com - November 24 at 9:14 AM
OpGen (OPGN) and Compugen (CGEN) Head-To-Head AnalysisOpGen (OPGN) and Compugen (CGEN) Head-To-Head Analysis
www.americanbankingnews.com - November 22 at 3:18 AM
OpGen, Inc. (OPGN) Expected to Post Quarterly Sales of $910,000.00OpGen, Inc. (OPGN) Expected to Post Quarterly Sales of $910,000.00
www.americanbankingnews.com - November 14 at 2:14 PM
OpGen, Inc. (OPGN) Upgraded by Zacks Investment Research to BuyOpGen, Inc. (OPGN) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - November 14 at 6:30 AM
OpGen, Inc. (OPGN) Expected to Post Earnings of -$0.06 Per ShareOpGen, Inc. (OPGN) Expected to Post Earnings of -$0.06 Per Share
www.americanbankingnews.com - November 12 at 1:08 AM
OpGens (OPGN) CEO Evan Jones on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaOpGen's (OPGN) CEO Evan Jones on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - November 11 at 8:02 AM
OpGen, Inc. to Host Earnings CallOpGen, Inc. to Host Earnings Call
finance.yahoo.com - November 9 at 10:28 AM
Edited Transcript of OPGN earnings conference call or presentation 7-Nov-17 9:30pm GMTEdited Transcript of OPGN earnings conference call or presentation 7-Nov-17 9:30pm GMT
finance.yahoo.com - November 9 at 10:28 AM
OpGens (OPGN) "Buy" Rating Reaffirmed at HC WainwrightOpGen's (OPGN) "Buy" Rating Reaffirmed at HC Wainwright
www.americanbankingnews.com - November 8 at 10:26 PM
OpGen Reports 2017 Third Quarter Financial Results and Provides Business UpdateOpGen Reports 2017 Third Quarter Financial Results and Provides Business Update
feeds.benzinga.com - November 7 at 4:43 PM
ETFs with exposure to OpGen, Inc. : November 1, 2017ETFs with exposure to OpGen, Inc. : November 1, 2017
finance.yahoo.com - November 2 at 7:19 AM
OpGen, Inc. (OPGN) to Release Quarterly Earnings on TuesdayOpGen, Inc. (OPGN) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - October 31 at 2:48 PM
OpGen Announces Date of Third Quarter 2017 Financial Results Conference Call - GlobeNewswire (press release)OpGen Announces Date of Third Quarter 2017 Financial Results Conference Call - GlobeNewswire (press release)
globenewswire.com - October 27 at 9:13 AM
OpGen Announces Date of Third Quarter 2017 Financial Results Conference CallOpGen Announces Date of Third Quarter 2017 Financial Results Conference Call
finance.yahoo.com - October 27 at 9:12 AM
Can OpGen Inc (OPGN) Improve Your Portfolio Returns?Can OpGen Inc (OPGN) Improve Your Portfolio Returns?
finance.yahoo.com - October 24 at 8:04 AM
OpGen Awarded CDC Contract to Develop Clinical Support Tools for Antimicrobial Stewardship and Infection ControlOpGen Awarded CDC Contract to Develop Clinical Support Tools for Antimicrobial Stewardship and Infection Control
feeds.benzinga.com - October 23 at 11:49 AM
Should You Be Concerned About OpGen Inc’s (OPGN) Investors?Should You Be Concerned About OpGen Inc’s (OPGN) Investors?
finance.yahoo.com - October 20 at 7:12 AM
ETFs with exposure to OpGen, Inc. : October 18, 2017ETFs with exposure to OpGen, Inc. : October 18, 2017
finance.yahoo.com - October 19 at 7:11 AM
OpGen, Inc. (OPGN) to Release Quarterly Earnings on MondayOpGen, Inc. (OPGN) to Release Quarterly Earnings on Monday
www.americanbankingnews.com - October 16 at 5:46 AM
OpGen to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference - GlobeNewswire (press release)OpGen to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference - GlobeNewswire (press release)
globenewswire.com - October 15 at 3:28 AM
OpGen to Present at Dawson James Securities 3rd Annual Small Cap Growth ConferenceOpGen to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference
finance.yahoo.com - October 13 at 7:47 AM
When Will OpGen Inc (OPGN) Run Out Of Money?When Will OpGen Inc (OPGN) Run Out Of Money?
finance.yahoo.com - October 5 at 1:57 PM
Contrasting Caladrius Biosciences (CLBS) and OpGen (OPGN)Contrasting Caladrius Biosciences (CLBS) and OpGen (OPGN)
www.americanbankingnews.com - October 5 at 9:46 AM
-$0.11 Earnings Per Share Expected for OpGen, Inc. (OPGN) This Quarter-$0.11 Earnings Per Share Expected for OpGen, Inc. (OPGN) This Quarter
www.americanbankingnews.com - October 4 at 6:28 AM
ETFs with exposure to OpGen, Inc. : October 2, 2017ETFs with exposure to OpGen, Inc. : October 2, 2017
finance.yahoo.com - October 2 at 8:43 PM
OpGen to Present at the Ladenburg Thalmann 2017 Healthcare ConferenceOpGen to Present at the Ladenburg Thalmann 2017 Healthcare Conference
finance.yahoo.com - September 22 at 7:32 AM
ETFs with exposure to OpGen, Inc. : September 19, 2017ETFs with exposure to OpGen, Inc. : September 19, 2017
finance.yahoo.com - September 20 at 7:19 AM
OpGen, Inc. :OPGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017OpGen, Inc. :OPGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017
finance.yahoo.com - September 19 at 6:15 AM
$860,000.00 in Sales Expected for OpGen, Inc. (OPGN) This Quarter$860,000.00 in Sales Expected for OpGen, Inc. (OPGN) This Quarter
www.americanbankingnews.com - September 17 at 7:50 AM
-$0.11 Earnings Per Share Expected for OpGen Inc (OPGN) This Quarter-$0.11 Earnings Per Share Expected for OpGen Inc (OPGN) This Quarter
www.americanbankingnews.com - September 15 at 2:28 PM
OpGen, Inc. (OPGN) PT Set at $1.00 by HC WainwrightOpGen, Inc. (OPGN) PT Set at $1.00 by HC Wainwright
www.americanbankingnews.com - September 11 at 8:58 PM
OpGen Data on New Rapid Gene Test and Antibiotic Susceptibility Prediction Algorithms Presented at the 2017 ASM/ESCMID ConferenceOpGen Data on New Rapid Gene Test and Antibiotic Susceptibility Prediction Algorithms Presented at the 2017 ASM/ESCMID Conference
finance.yahoo.com - September 9 at 7:02 AM
OpGen, Inc. (OPGN) Expected to Post Quarterly Sales of $860,000.00OpGen, Inc. (OPGN) Expected to Post Quarterly Sales of $860,000.00
www.americanbankingnews.com - August 30 at 2:54 PM
OpGen, Inc. (OPGN) Expected to Announce Earnings of -$0.11 Per ShareOpGen, Inc. (OPGN) Expected to Announce Earnings of -$0.11 Per Share
www.americanbankingnews.com - August 28 at 2:18 AM
OpGen, Inc. (OPGN) Sees Large Increase in Short InterestOpGen, Inc. (OPGN) Sees Large Increase in Short Interest
www.americanbankingnews.com - August 28 at 1:20 AM
Short Interest in OpGen, Inc. (NASDAQ:OPGN) Increases By 24.3%Short Interest in OpGen, Inc. (NASDAQ:OPGN) Increases By 24.3%
www.americanbankingnews.com - August 13 at 2:20 AM
Edited Transcript of OPGN earnings conference call or presentation 8-Aug-17 8:30pm GMTEdited Transcript of OPGN earnings conference call or presentation 8-Aug-17 8:30pm GMT
finance.yahoo.com - August 10 at 6:34 AM
Investor Network: OpGen, Inc. to Host Earnings CallInvestor Network: OpGen, Inc. to Host Earnings Call
finance.yahoo.com - August 9 at 6:06 AM
OpGen Reports 2017 Second Quarter Financial Results and Provides Business UpdateOpGen Reports 2017 Second Quarter Financial Results and Provides Business Update
finance.yahoo.com - August 9 at 6:06 AM
ETFs with exposure to OpGen, Inc. : August 4, 2017ETFs with exposure to OpGen, Inc. : August 4, 2017
finance.yahoo.com - August 4 at 6:44 AM
OpGen Announces Closing of $10 Million Public OfferingOpGen Announces Closing of $10 Million Public Offering
finance.yahoo.com - July 20 at 5:48 AM

SEC Filings

OpGen (NASDAQ:OPGN) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

OpGen (NASDAQ:OPGN) Income Statement, Balance Sheet and Cash Flow Statement

Chart

OpGen (NASDAQ OPGN) Stock Chart for Sunday, December, 17, 2017

Loading chart…

This page was last updated on 12/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.